Haiqiang Wu

机构：Anhui Agricultural University, Shenzhen University, Shenzhen Bay Laboratory, Shenzhen University Health Science Center, Shenzhen Nanshan Center for Chronic Disease Control · ORCID：0000-0003-3979-7304

发表论文 113 篇 · 总被引 2610 次 · h-index 29

代表论文

• A ROS-responsive hydrogel that targets inflamed mucosa to relieve ulcerative colitis by reversing intestinal mucosal barrier loss (2024 · Journal of Controlled Release · 被引 33)
• Chitosan-based oral nanoparticles as an efficient platform for kidney-targeted drug delivery in the treatment of renal fibrosis (2023 · International Journal of Biological Macromolecules · 被引 33)
• Design, Synthesis, and Activity Evaluation of BRD4 PROTAC Based on Alkenyl Oxindole-DCAF11 Pair (2024 · Journal of Medicinal Chemistry · 被引 19)
• Isolation and Identification of Chemical Compounds from Agaricus blazei Murrill and Their In Vitro Antifungal Activities (2023 · Molecules · 被引 8)
• An In Situ Sustained-Release Chitosan Hydrogel to Attenuate Renal Fibrosis by Retaining Klotho Expression (2024 · Biomaterials Research · 被引 6)
• Cavidine alleviates paclitaxel-induced peripheral neuropathy by promoting mitochondrial autophagy through inhibiting PKM2-mediated histone lactylation (2025 · Free Radical Biology and Medicine · 被引 4)